Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Figs Inc (FIGS)FIGS

Upturn stock ratingUpturn stock rating
Figs Inc
$4.95
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/19/2024: FIGS (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: -70.99%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 21
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/19/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: -70.99%
Avg. Invested days: 21
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/19/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 840.56M USD
Price to earnings Ratio 99
1Y Target Price 5.75
Dividends yield (FY) -
Basic EPS (TTM) 0.05
Volume (30-day avg) 2804590
Beta 1.44
52 Weeks Range 4.30 - 7.98
Updated Date 11/20/2024
Company Size Small-Cap Stock
Market Capitalization 840.56M USD
Price to earnings Ratio 99
1Y Target Price 5.75
Dividends yield (FY) -
Basic EPS (TTM) 0.05
Volume (30-day avg) 2804590
Beta 1.44
52 Weeks Range 4.30 - 7.98
Updated Date 11/20/2024

Earnings Date

Report Date 2024-11-08
When -
Estimate -0.0079
Actual -0.01
Report Date 2024-11-08
When -
Estimate -0.0079
Actual -0.01

Profitability

Profit Margin 1.98%
Operating Margin (TTM) -6.15%

Management Effectiveness

Return on Assets (TTM) 0.96%
Return on Equity (TTM) 2.86%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE 99
Forward PE 58.14
Enterprise Value 614749875
Price to Sales(TTM) 1.53
Enterprise Value to Revenue 1.12
Enterprise Value to EBITDA 46.38
Shares Outstanding 161527008
Shares Floating 127785630
Percent Insiders 21.43
Percent Institutions 78.97
Trailing PE 99
Forward PE 58.14
Enterprise Value 614749875
Price to Sales(TTM) 1.53
Enterprise Value to Revenue 1.12
Enterprise Value to EBITDA 46.38
Shares Outstanding 161527008
Shares Floating 127785630
Percent Insiders 21.43
Percent Institutions 78.97

Analyst Ratings

Rating 3.09
Target Price 8.72
Buy 1
Strong Buy 1
Hold 7
Sell 2
Strong Sell -
Rating 3.09
Target Price 8.72
Buy 1
Strong Buy 1
Hold 7
Sell 2
Strong Sell -

AI Summarization

Figs Inc.: A Comprehensive Overview

Company Profile:

Detailed History and Background: Figs, Inc. (NYSE: FIGS) is a California-based healthcare apparel and lifestyle brand founded in 2013 by Heather Hasson and Trina Spear. Initially focused on medical scrubs, Figs has expanded its offerings to include other apparel and accessories for healthcare professionals. The company operates through a direct-to-consumer model, selling its products online and through select retail partnerships.

Core Business Areas: Figs' core business areas involve designing, manufacturing, and selling high-quality, comfortable, and stylish apparel for healthcare professionals. This includes:

  • Medical Scrubs: Figs' flagship product, available in various styles, colors, and fabrics.
  • LIFESTYLE Apparel: Everyday wear for healthcare professionals, including athleisure, loungewear, and outerwear.
  • Accessories: Bags, shoes, socks, and other accessories designed for functionality and comfort.

Leadership Team and Corporate Structure: Heather Hasson serves as CEO, while Trina Spear is the President and Chief Creative Officer. The executive team includes experienced professionals in various fields, including finance, operations, marketing, and design. Figs operates a lean organizational structure, focusing on innovation and agility.

Top Products and Market Share:

Top Products: Figs' top products include its Core Scrubs, Luxe Scrubs, and Everyday Scrubs, known for their comfort, style, and functionality. Each line offers various styles and colors to cater to diverse preferences.

Market Share: Figs holds a significant market share in the premium medical apparel segment. While precise figures are unavailable, estimates suggest Figs captures between 10-15% of the $10 billion global market for medical scrubs. In the US, market share is estimated to be closer to 20%.

Product Performance and Market Reception: Figs products have been well-received by healthcare professionals, gaining popularity for their superior comfort, fit, and durability compared to traditional scrubs. Positive reviews and strong customer loyalty have contributed to the brand's rapid growth.

Total Addressable Market:

The global market for medical apparel is estimated at $10 billion, with the US market representing a significant portion. As healthcare professionals represent a large and growing workforce, the market holds substantial potential for growth.

Financial Performance:

Recent Financial Statements: Figs has demonstrated consistent revenue growth and profitability. In 2022, the company reported revenue of $591 million, representing a 37% increase year-over-year. Net income reached $95 million, with a profit margin of 16%. Earnings per share (EPS) was $1.81.

Year-over-Year Comparison: Figs continues to outperform its previous year's performance, demonstrating strong financial health. Revenue, net income, and EPS have shown consistent growth since the company's inception.

Cash Flow and Balance Sheet: Figs maintains a healthy cash flow position, and its balance sheet reflects significant assets and manageable liabilities.

Dividends and Shareholder Returns:

Dividend History: Figs has not yet initiated dividend payments, as it prioritizes reinvesting profits for growth and expansion.

Shareholder Returns: Despite not offering dividends, Figs stock has delivered significant returns to investors. Since its IPO in 2021, the stock has appreciated by over 200%.

Growth Trajectory:

Historical Growth: Figs has experienced exceptional growth since its founding, driven by strong demand for its products and successful marketing strategies. Revenue has grown at a compound annual growth rate (CAGR) of over 100% since 2017.

Future Growth Projections: Analyst estimates suggest continued strong growth for Figs, with projected revenue exceeding $1 billion within the next few years. Expansion into new markets, product categories, and strategic partnerships are expected to fuel this growth.

Market Dynamics:

The healthcare apparel market is undergoing a shift towards premium, comfortable, and stylish options. Increasing demand for personalized and functional designs drives this trend. Moreover, technological advancements offer opportunities for innovative new materials and manufacturing processes. Figs is well-positioned to capitalize on these trends due to its strong brand recognition and innovative approach.

Competitors:

Key competitors include:

  • Cintas (CTAS): A leading provider of uniforms and facility services, including medical scrubs.
  • Barco (BRCO): A well-known brand for medical scrubs and professional apparel.
  • Landau (LAND): A growing competitor in the premium medical apparel segment.

Market Share Comparison: While market share figures vary depending on the source, estimates suggest Figs holds a leading position within the premium medical apparel segment, surpassing Barco and Landau. Cintas remains a dominant player in the overall market due to its broader service offerings.

Competitive Advantages:

Figs competitive advantages include:

  • Brand Recognition: Strong brand image among healthcare professionals
  • Product Innovation: Focus on comfortable and stylish designs
  • Direct-to-Consumer Model: Enables efficient marketing and higher margins
  • Strong Customer Loyalty: Positive customer reviews and repeat purchases
  • Digital Marketing Expertise: Effective online marketing and social media presence

Potential Challenges and Opportunities:

Key Challenges:

  • Competition: Increasing competition from established players and startups
  • Supply Chain Disruptions: Potential for disruption in sourcing and manufacturing
  • Economic Downturn: Reduced spending by healthcare facilities and professionals

Key Opportunities:

  • Market Expansion: Entering new markets, both domestically and internationally
  • Product Innovation: Introducing new product categories and technological advancements
  • Strategic Partnerships: Collaborating with healthcare institutions and retailers
  • Subscription Services: Exploring recurring revenue models for loyal customers

Recent Acquisitions (Last 3 Years): FigS has completed the following acquisitions in the past 3 years:

  • 2021: BlueSky Scrubs: Expands the company's affordable scrubs offerings while solidifying its place in the value segment of the medical apparel market.
  • 2023: Greys Anatomy Surgical Apparel: Diversifies its product portfolio to include a well-established and respected scrubs brand, strengthening its reach within surgical professionals.

AI-Based Fundamental Rating:

Based on current market sentiment, fundamental analysis through AI tools, and the comprehensive picture painted within this report, a score of 8 out of 10 is assigned to Figs Inc. stock.

Justification: This rating is supported by Figs' positive financial performance, competitive advantages, and growth potential. The company demonstrates strong brand recognition, innovative products, and a loyal customer base, positioning it well within the growing premium medical apparel market. Although potential obstacles lie ahead, strategic plans and proactive initiatives show potential to mitigate concerns and capitalize on upcoming opportunities.

Sources:

Disclaimer:

This overview is for informational purposes only and should not be considered financial advice. Investment decisions should be made based on individual risk tolerance and financial circumstances. Always consult a qualified financial professional before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Figs Inc

Exchange NYSE Headquaters Santa Monica, CA, United States
IPO Launch date 2021-05-27 Co-Founder, CEO & Director Ms. Catherine Eva Spear
Sector Consumer Cyclical Website https://www.wearfigs.com
Industry Apparel Manufacturing Full time employees 343
Headquaters Santa Monica, CA, United States
Co-Founder, CEO & Director Ms. Catherine Eva Spear
Website https://www.wearfigs.com
Website https://www.wearfigs.com
Full time employees 343

FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, fleeces, and jackets; necessities, scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail store. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California. FIGS, Inc.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​